Acesion Pharma

Acesion Pharma is a biotech company in Copenhagen, Denmark, founded in 2011. It has raised $63.1M across 3 rounds, most recently a $52.5M Series B in September 2023.

Pioneering safer and more effective treatments for atrial fibrillation

Headquarters
Copenhagen
Employees
11–50
Founded
2011
Business Model
B2B
Total Funding
$63.1M
Last Round
$52.5M Series BSep 2023
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 7 investors for this company. The full record is or through the API.

About

Acesion Pharma ApS is a Danish clinical-stage biotech company founded in 2011 and based in Frederiksberg (Copenhagen), Denmark. The company is pioneering the development of novel SK ion channel inhibitors for the treatment of atrial fibrillation (AF), the most common cardiac arrhythmia. Its technology is based on research initiated in 2008 at the University of Copenhagen and chemistry insights from Neurosearch. Existing drug therapies for AF have limited efficacy and significant safety risks; Acesion's approach — inhibiting SK channels that regulate heart rhythm — represents the first new therapeutic principle for AF treatment in over 20 years. The company advanced its lead compound AP30663 through a successful Phase 2 trial (primary endpoint met, March 2023) and initiated a Phase 2 trial of AP31969 in January 2026.

Summary

It lists 11–50 employees. It has raised $63.1M in total across 3 rounds, most recently a $52.5M Series B round in Sep 2023. Investors include Canaan Partners, Alpha Wave Ventures and Global BioAccess Fund.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BSep 2023
$52.5M

Sign up to see all 3 events

Funding: Venture Round through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Acesion Pharma on Indexed.vc
<a href="https://indexed.vc/companies/acesion-pharma"><img src="https://indexed.vc/api/badge/company/acesion-pharma" alt="Acesion Pharma on Indexed.vc" width="260" height="76" /></a>